Книга_5541_Библиотеки_им_академика_М_И_Перельмана

Добавил:

Sekretar kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.

Вуз:

Ростовский Государственный Медицинский Университет

Предмет:

Медицина общая

Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5541_Библиотеки_им_академика_М_И_Перельмана.pdf

Скачиваний:

Добавлен:

09.09.2026

Размер:

18 Мб

Скачать

☆

<<< < Предыдущая 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 3637 / 3837 38 > Следующая >>>

344 Subject Index

General intelligence, 88 Generalized anxiety disorder (GAD),

199

developmental course, 203

Genes

ADHD and, 163–164 anxiety and depression development,

205 anxiety-based disorders, 205 bipolar disorders, 229 cognitive and intellectual development,

89–90 effects and environments,

definitions, 20 depressive disorders, 225–226 eating disorders, 246 and environments effects, 18–23 factors contributing to stress

reactivity, 150 learning disorders, 105–106 variants for autism spectrum

disorder, 124 vulnerability to substance-related

disorders and, 264

Genetics, 18–23 Genetic screening/counseling, 102 Genetic syndromes

Down syndrome, 94 fragile X syndrome, 94–95 Williams syndrome, 94

Genome-wide association studies, 18 Genotype, 18

intellectual developmental disorder,

93–94

Goodness of fit, 71 Group interventions

eating disorders, 251–252 substance-related disorders, 267–268

Growth dysregulation hypothesis, 124

Heredity

ADHD, 163 autism spectrum disorder, 124 anxiety-based disorders, 205 bipolar disorders, 229 depressive disorders, 225–226 eating disorders, 246 intellectual and cognitive development,

89–90 vulnerability to substance-related

disorders, 264

Heritability, 19 Heterogeneity, 54 Heterotypic continuity, 203 Hierarchical Taxonomy of

Psychopathology (HiTOP), 55 Research Domain Criteria (RDoC)

models, 56–57

Histone modifications, 22 Homotypic continuity, 203

Hopelessness model, 227 Human connectome, 16 Humanistic models, 26 Hypomania, 223

IDEA, 61, 90–91

children with intellectual disabilities,

97 Identity, construction of, 215–216 Impulsivit y, 156 Incentive motivation, 255 Incentive salience, 264 Incentive-sensitization theory, 264 Incidence, 6

rates for ADHD and autism (sex/age

group), 9

rates for anxiety, depression, and eating

disorders (sex/age group), 8–9 Inclusion

children with ASD, 130–131

teachers’ attitudes toward, 98 Incompetence, 38 Incredible Years program, 188 Indicated preventive measures, 63 Individualized Education Plans (IEPs),

92, 106 Individual risk factors, 40 Individuals with Disabilities Education

Improvement Act of 2002. See

IDEA Infancy

attachment formation, 71–74 temperament, 68–71 rates of disorders, 6 temperament 68–71

Inhibition, 157

anxiety-based disorders and, 206

Insecure attachment, 72, 75–76

anxiety disorders, 207 Instrumental aggression, 179 Intellectual development, 88

genes, the brain, and the environment,

89–90

Intellectual developmental disorder,

91–92 adult outcomes, 99 assessment and diagnosis, 100 case study, 92–93 developmental course, 96–97 etiology, 95–96 executive function, 97 family education and support, 103 genetic risk, 95 genetic screening and prevention

strategies, 102 genotypes and neurobehavioral

phenotypes, 93–94 intervention, 101–102 language and communication

abilities, 97

maladaptive behaviors and comorbid

disorders, 99

pharmacological treatment, 102–103

prevention, 102 psychological treatment, 103 risk and resilience processes, 100 risk factors, 95 role of family, 99–100 socioemotional functioning,

motivation, and personality, 97–100

Zigler’s approach, 93

Intellectual disability. See Intellectual

developmental disorder

Intellectual functioning, 91

assessment, 100

Intelligence

Cattell-Horn-Carroll (CHC) model,

88 components and mechanisms, 88 developmental tasks and challenges,

88 measurement, 90–91

Intergenerational child maltreatment,

145

Internalizing behaviors, 52

substance-related disorders, 261

Internalizing disorders. See also Anxiety

disorders anxiety disorders, 194–195 temperamental inhibition, 75–76

Internal validity, 52 Interpersonal–psychological theory of

suicidality, 235

Interpersonal therapy

eating disorders, 251 mood disorders, 232

Interpersonal trauma, 142, 143 Interrater reliability, 52 Intervention, 62–63

ADHD, 166–169 anti-bullying programs, 176 antisocial pathways model, 188, 189 anxiety disorders, 209–212 autism spectrum disorder, 128–131 avoidant/restrictive food intake

disorder, 78 child maltreatment, 152–154 disorders of attachment, 85 early childhood, evidence-based

approach, 79 eating disorders, 248–252 intellectual developmental disorder,

101–103 learning disorders, 106–107 mood disorders, 231–233 oppositional defiant and conduct

disorders, 187–191 pre-symptomatic framework, 129 primary, secondary, and tertiary, 63–64 PTSD, 152

Copyright 2024 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).

Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.

Subject Index 345

sleep–wake disorders, 80 substance-related disorders,

266–268 parent and child timing, 188, 189 working with parents and families, 64 working with schools and communities,

64–65

Interviews

assessment, 58–60

Intrusion symptoms, 140 IQ scores

bimodal distribution, 91 for siblings of individuals with

IDD, 96

IQ testing, 90 Irritability, 75, 230

Joint attention, 111

Kanner, Leo, 110 Kaufman Assessment Battery for

Children, 91

Kiddie Schedule for Affective Disorders

and Schizophrenia (K-SADS),

Kindling model, 227

Lack of protective shield effect, 151 Language

impairments, in ASD, 119 intellectual disability, 97

Learning disorders, 103–105

assessment, diagnosis, and intervention,

106 –107 case study, 103–104 developmental course, 105 etiology, 105–106

Learning outcomes, and intellectual

disability, 97

Life-course persistent (LCP) trajectory of

CD, 178

Life cycle model, 134–135 Little Six dimensions of personality,

256, 258

Longitudinal research, 47

Major depressive disorder, 218–219 Maladaptation, 2 Maladaptive anxious emotion, 203 Maladaptive behaviors, in children with

intellectual disabilities, 99

Maltreatment, 43, 138–139. See also

Child maltreatment case study, 137–138 and depression, 145, 146 depressive disorders, 229 disclosure, 151

dissociation, 144 ecological-transactional model,

149–150 long-term outcomes, 145 neurodevelopmental models, 150 prevention of, 154 protective factors, 43 PTSD, 142, 143 resilience, 145–146 risk factors, 43 short-term outcomes, 144–145

Mania, 222–223 Marijuana use, 260–261

trajectories, 262

Marshmallow test, 156 –157 Mass trauma events

intervention efforts, principles, 152 posttraumatic stress disorder, 141

MATCH approach, 189 Maturity principle, 257 Maudsley model of family therapy,

251

Meanness, 183 Media, influence of on body

image, 240

Mental health

definitions, 3–4 frequency of treatments, 10 and gender diversity, 222 globa lization, 11 stigmatization, 10 treatment availability, lack of, 9–10

Mentalizing, 24 Methylphenidate, 167 Mindblindness, 113 Minnesota Executive Function Scale

(MEFS), 157

Modeling treatments, 211 Modified Checklist for Autism in

Toddlers (M-CHAT), 127

Molecular genetics, 18 Mood disorders. See also Bipolar

disorders; Depressive disorders assessment and diagnosis of in

adolescents, 231 assessment and diagnosis of in children,

230–231 family treatment, 232–233 intervention, 231–232

Motivation, in youth with intellectual

disabilities, 98–99

Motivational deficits, and ADHD, 164 Motivational interviewing, 267 MTA Cooperative Group Study, 167 Multidimensional Anxiety Scale for

Children (MASC), 208

Multifinality, 36 Multimodal Treatment Study of

Children with ADHD. See MTA

Cooperative Group Study

Multisystemic therapy, 190

Multitiered systems of support

(MTSS) model. See Response to intervention (RTI)

National Child Traumatic Stress Network

(NCTSN), 143, 152

National Emergency in youth mental

health, recommendations, 7

National Institute on Drug Abuse,

260

Natural disasters, posttraumatic stress

disorder, 141

Naturalistic behavioral developmental

interventions (NBDIs), 129–130 Negative affectivity, 69 Negative body image, 240 Negative life events, 230, 235, 248 Neglect, 138 Neglected children, 174 Neural plasticity, 17 Neurobehavioral phenotypes, intellectual

developmental disorder, 93–94 Neurodiversity framework, 110 Neurophysiology

ADHD, 164 anxiety-based disorders, 206 autism spectrum disorder, 125 bipolar disorders, 230 depressive disorders, 226 oppositional defiant and conduct

disorders, 184

substance-related disorders, 265 Neurotransmitters, 16 Nondestructive tantrums, 220 Nonshared environment, 28 Nonspecific risk, 40 Nonsuicidal self-injury (NSSI),

233, 234 in adolescence and emerging adulthood, 234

Nonverbal learning disabilities, 104 Normality, 2–4 North American Prodrome Longitudinal

Study (NAPLS), 270–271, 272

Observation

assessment, 61 assessment of ADHD, 165–166

Observational learning, 25 Obsessions, 201 Obsessive-compulsive disorder (OCD).

See OCD

OCD, 200–202. See also Anxiety

disorders case study, 200–201 continuity and course, 203 distinct symptom dimensions, 201 intrusive thoughts, 207 psychological treatment, 211

346 Subject Index

Operant conditioning, 25 Oppositional defiant disorder (ODD),

176–177 assessment and diagnosis, 187 case studies, 176 child and adolescent factors, 184–185 cognitive-behavior approaches, 188 developmental course, 179–182 dimensional approaches, 176–177 irritability and dysregulation,

developmental pathways, 179, 180 physiological factors, 184 prevalence, 177 prevention efforts, 190–191 role of genes and heredity, 184 school programs, prevention-oriented,

190–191

Orchid children, 22 Oregon model, 180–181, 189 Outcome research, 63 Over-pruning hypothesis, 124 Overt aggression, 179

Pain processes, 234 Pandemic. See COV ID-19 pa ndemic Panic disorder, 200 Parasuicide, 233 Parent–child emotion regulation

model, 228

Parent–Child Interaction Therapy

(PCIT), 152, 189

Parent–child mutually responsive

orientation (MRO), 173

Parent factors

anxiety disorders and OCD,

207–208 child maltreatment, 151 eating disorders, 247–248 oppositional defiant and conduct

disorders, 185–186 PTSD development, 151 substance-related disorders, 262

Parenting

children with ADHD, 160–161 development of prosocial behavior,

173 infant temperament, 70 negative practices, and risk for ODD/

CD, 185–186 parental beliefs, 28 styles and development of ODD,

28, 180

Parent management training (PMT),

189, 232

Parents

assessment interviews, 59–60 working with, 64

Partial fetal alcohol syndrome (PFAS),

Pathways of parental impact, 228

Patterson, Gerald, 180 Pediatric Innovation Initiative (PII),

48 Peer contagion, 183, 190, 235 Peer factors

conduct-disordered youth, 190 ODD and CD, 186–187

substance-related disorders, 262 Peer rejection, 163 Peer relationships, prosocial behavior,

173–174 Peers role in development, 28–29 Penn Resiliency Program (PRP), 233 Perfectionism, eating disorders, 247 Persistent depressive disorder, 219 Personality

Big Five model, 256 characteristics and skills, 257–258 children with intellectual disabilities,

97–98

disruptive behavior disorders, 185 developmental tasks and challenges

related to, 255–258

genes, shared/nonshared environments,

Little Six dimensions, 256, 258 pathology, terms used for

describing, 268

temperament and development, 71

Personality disorders

adolescence and young adulthood,

270–274

developmental perspectives,

268–269

DSM-5-TR categorical syndromes,

269 p factor, 55 Pharmacological treatment

ADHD, 166–168 anxiety-based disorders, 209 autism spectrum disorder, 129 intellectual developmental disorder,

102–103

mood disorders, 232

Pharmacotherapy, in ADHD treatment,

167–168 Phenotype, 18 Phobic disorders, 197–198

psychological treatment, 211 Physical abuse, 138 Physical aggression, 174 Physical dependence, 259 Physiological factors

ADHD, 164

anxiety-based disorders, 206

autism spectrum disorder, 124–125

depressive disorders, 226

eating disorders, 246–247

maltreated children, 144

oppositional defiant and conduct

disorders, 184

substance-related disorders, 264 trauma- and stress-related

disorders, 150 Physiological functioning, 68 Physiological measures of assessment, 61 Physiological models, 15, 23

brain-body-behavior processes, 18 brain growth (see Brain development) brain maturation, events sequence, 16 brain structure and function, 15–16 connectome, 16 disorder, 19–23

genes and environments, 18–19 Pica, 76 Polygenic models, 20–21 Polypharmacy, with ADHD,

167–168 Poly-victimization, 145 Positive control, 70 Positive Discipline in Everyday Parenting

(PDEP), 190 Positive identity, construction of,

215–216 Positive parenting, development of

prosocial behavior and, 173 Positive psychology models, 26 Positive stress responses, 135 Positive youth development, 26, 31, 40,

46, 64, 190 Posttraumatic growth, 149 Posttraumatic stress disorder (PTSD).

See PTSD Poverty

contribution to child maltreatment, 150 depressive disorders, 230 risk, 41

Prader-Willi syndrome, 93, 98. See also

Intellectual developmental disorder Prefrontal cortex, maturation of, 255 Prescription drugs, abuse of, 261 Prevalence, 6

ADHD diagnosis, 160 ODD and CD, 180–181 anxiety disorders, 195 autism spectrum disorder, 117–118 bipolar disorders, 223 depressive disorders, 220 eating disorders, 244 Fetal alcohol spectrum disorder

(FASD), 95

generalized anxiety disorder, 199 intellectual developmental disorder,

multiple phobias, 198 obsessive-compulsive disorder,

199, 202

oppositional defiant disorder

(ODD), 177

social phobia, 198 specific phobias, 197 suicidality, 233–234

Subject Index 347

Preventive measures, 63

autism spectrum disorder, 128 eating disorders, 248 externalizing behaviors, 190–191 mood disorders, 233 strategies for intellectual disability,

102 substance-related disorders, 266 externalizing behaviors, 190–191

Primary prevention, 63 Problematic eating behaviors, 243 Problem solving, 137, 209, 210 Process research, 63 Prodrome phase, 272 Projective measures, 60–61 Promotive effects, 44 Prosocial behavior, challenges related

to, 172–175

Prosociality, 172 Prosocial motivation, 172 Prosocial refusals, 174 Prospective self, 258 Protective effects, 44 Protective factors, 40

patterns and pathways, 45–46 resilience, 43 types, 44–45

Psychodynamic models, 24 Psychoeducation, 209 Psychological dependence, 259–260 Psychological domain, consequences of

ma ltreatment, 144–145

Psychological factors, and treatments

of ADHD, 164 anxiety-based disorders and OCD,

209–212 autism spectrum disorder, 129–130 eating disorders, 247 intellectual developmental disorder, 103 substance-related disorders, 264

Psychological well-being

mental health perspective, 3–4

Psychopathology

behavioral understanding, 25 cognitive approaches, 25 definition, 6 developmental principles, research for

SITBs, 235 family models, 27–29 fixation–regression model, 24 genetic and epigenetic approaches,

18–23 hierarchical taxonomy, 56 humanistic approaches, 26 lifespan understanding, 270 medical model, 51 psychodynamic approaches, 18–23 sociocultural understanding, 29–32 stigmatization, 10 temperament and attachment to, 75–76 triarchic model, 185

Psychopathy, 185 Psychosis, 270

transition, 270–271

Psychosis prodrome, 270

developmental factors, 272

Psychotherapy, efficacy for children and

adolescents, 63

Psychotic disorders

case study, 270–272 occurrence in adolescence and young

adulthood, 270–274

PTSD, 140

assessment and diagnosis, 151–152 developmental pathways, 148 long-term outcomes, 148 neurodevelopmental models of, 150 resilience, 148 –149 short-term outcomes, 147–148 treatment, 152

Qualitative models of psychopathology,

Quality-of-life (QOL)

framework, 92, 100 interventions, 102

Quantitative models of

psychopathology, 15

Racism, and discrimination, 31, 229 Rates of suicidality, 233–234 Rating scales

ADHD, 165–166

ASD, 127 Reactive aggression, 179 Reactive attachment disorder (RAD),

80–82 Reactivity, 68 Recovery After an Initial Schizophrenia

Episode (RAISE) project, 274 Regulation, 68–69. See also Emotion

regulation (ER), strategies Reinforcement, 25 Reinforcement model of depression, 228 Relapse prevention, 209, 210 Relational aggression, 174, 179 Reliability of classification, 52 Research Domain Criteria (RDoC),

55, 143

Hierarchical Taxonomy of

Psychopathology (HiTOP) models,

56–57 Research strategies, 46

complex hypotheses and complex

models, 47

cross-sectional and longitudinal

approaches, 46–47

real-world settings, 47, 49

Resilience, 40

adaptation-based approach to, 46

child maltreatment, 145–146 children and adolescents with

IDD, 100

pathways, for autistic individuals,

123 protective factors, 43–46 system-focused approach, 43, 44 trauma, 149

Resistant attachment, 72–73 Resources, allocation of, 7–10 Response to intervention (RTI), 106 Restricted, repetitive behaviors (RRBs),

115–116

Revised Children’s Manifest Anxiety

Scale (RCMAS), 208

Reward/circadian rhythm dysregulation

model, 230

Reward hypersensitivity model, 230 Reynold’s Adolescent Depression Scale

(RADS), 60

Risk, 40

alleles, 20 and resilience, children in Romanian

orphanages, 83

Risk factors, 40

environmental, 42 intellectual developmental disorder,

95–96

timing, 42–43 types, 40–42

RNA signaling, 22 Romanian orphanages, risk and resilience

of children in, 83

Rumination, 76, 227

Schizophrenia, 272. See also Psychotic

disorders

School-based mental health services,

Schools

accommodations, 204 ADHD, 162–163 conduct-disordered children, 190 ASD, 130–131 special education services, 127 trauma-informed pedagogy, 153 working with, 64–65

Screen for Child Anxiety Related

Disorders (SCARED), 208

Secondary prevention, 64 Secure attachment, 72 Selective preventive measures, 63 Selective serotonin reuptake inhibitors

(SSRIs), 126

Self-harm, 233

in adolescence and emerging adulthood,

234

Self-injurious thoughts and behaviors

(SITBs), 233

348 Subject Index

Self-regulation

developmental tasks and challenges,

156, 255–258 Self-talk, 211 Sensation seeking vs. self-regulation,

257 Sense of self, 71

construction of, 215–216

Separation anxiety disorder, 195–197

psychological treatment, 211 Sexual abuse, 138 Shared environment, 28 Shyness vs. social phobia, 198 Siblings

experience, and relationships, 28 Sleep–wake disorders

assessment and diagnosis, 80

case study, 78

developmental course, 78–79

etiolog y, 80

intervention, 80 Sluggish cognitive tempo, 164 Social anxiety disorder, 197–198

developmental course, 203 Social brain models, of autism, 114 Social/circadian rhythm disruption,

230 Social cognition, and ASD, 111 Social deficits

ADHD, 161, 163 autism spectrum disorder, 113–115

Social engagement process, 114

deficits, in children with ASD,

113 –115 Social media, and body image, 240 Social motivation (brain) theories, 125 Social phobia, prevalence rates,

198 Social risk factors, 41 Socioaffective pain, 234 Sociocultural factors

child maltreatment, 150 influences on anxiety sensitivity,

195

ODD and CD, 186–187 risk factors, 41

substance-related disorders, 265 Sociocultural models, 29–32 Sociocultural norms, 3 Sociocultural protective factors, 44 Socioeconomic factors, and risk, 41 Socioeconomic status, 41

body dissatisfaction, 240

diagnoses of conduct disorder, 178

executive function, 157

substance use, 260 Socioemotional functioning

children with intellectual disabilities,

97–98 Somatic management, 209, 210 Somatic symptom disorders, 202

continuity and course, 205

psychological treatment, 211 Somatization, 202 Somatoform disorders. See Somatic

symptom disorders Special education services, 127 Specific learning disorder (SLD),

104–105 Specific phobias, 197

developmental course, 203 Specific risk, 40 Stability, 36–38 Standardized tests, 60–61 Stanford-Binet, 60, 91, 100

assessment of intellectual disabi

lity, 100 Statistical deviance, 3 Stigmatization, of mental illness, 10 Stimulant medications, to treat ADHD,

166 –167 Strengths and Difficulties Questionnaire

(SDQ ), 60 Stress, 134

and adversity in early development,

136

exposure influences, allostasis/allostatic

load, 135–136 Stressful life events, and risk, 41–42 Stressor-related disorders, 139–143,

150–151

assessment and diagnosis, 151–152

case study, 139–140, 147 Stressors, 134, 136 Stress–response system, 135, 136 Structured observation, 61 Substance Abuse and Mental Health

Services Administration, 260

Substance-related disorders,

258–262 assessment and diagnosis, 265–266 case studies, 258–259 developmental course, 262 etiolog y, 263 parents, peers, and sociocultural

factors, 265 physiological factors, 264 prevention strategies, 266 psychological factors, 265 role of genes and heredity, 263–264 treatment modalities, 266–268

Suicidal ideation, 233 Suicidality, 233–236

bipolar disorders, 223 developmental psychopathology

principles, use for research,

235–236 peer factors, 234–235 warning signs, 236

Suicide, 233 Surgency, 69, 226 Systematic desensitization, 211

Tantrums, 219–220 TEACCH model, 131 Teacher s

assessment and observations, 61 attitudes toward inclusion, 98

Tempera ment

and ADHD, cascade model,

162 definition, 68 dimension links with disorders,

75–76 early childhood development,

68–71 anxiety disorders, 206 personality characteristics over time,

71, 72 ODD/ CD risk, 185 relationship to psychopathology,

75–76 typological approaches, 69

Terrorism, PTSD in children, 141 Tertiary prevention, 64 Thematic Apperception Test (TAT),

60 –61

Theory

behavioral models, 25 cognitive models, 25 family models, 27–29 humanistic models, 26 physiological models, 15–23 positive psychology models, 26 psychodynamic models, 24 sociocultural models, 29–32

Theory of Mind (ToM), 111–112, 125 Therapeutic approaches

ADHD, 169 anxiety-based disorders, and OCD,

209–212 disorders of attachment, 85 eating disorders, 249–251 intellectual developmental disorder,

103 mood disorders, 232 oppositional defiant and conduct

disorders, 188–189 substance-related disorders,

266–268 trauma- and stress-related disorders,

152, 153

Tolerable stress responses, 135 Tolerance, 259 Top-down processing, 164 Toxic family effect, 151 Toxic stress, 47, 48, 135 Transdiagnostic model, linking trauma to

disorder, 149

Transdiagnostic symptoms, 54–55 Transgender and gender diverse

(TGD), 222

Translational research, 49

Subject Index 349

Trauma, exposure, 150 Trauma focused cognitive behavior

therapy (TF-CBT), 152

Trauma-informed pedagogy, principles

of, 153

Trauma-related disorders, 139–143,

150–151 assessment and diagnosis, 151–152 case study, 139–140, 147

Treatment and Education of Autistic and

Communication-Handicapped

Children. See TEACCH model

Triarchic model of psychopathy, 185 Triple P Positive Parenting program, 188

Universal Design for Learning (UDL)

framework, 98

Universal prevention programs/measures,

98, 266

Validity of classification, 52 Values

role of, 4–6

Vanderbilt ADHD Diagnostic Rating

Scale (VADRS), 166 Verbal learning disabilities, 104 Vineland Social Maturity Scale, 100 Violence, PTSD, 142, 143

War, posttraumatic stress disorder in

children, 141 Wechsler Intelligence Scales for Children

(WISC), 60, 91, 100

assessment of intellectual disability,

100 Williams syndrome, 94. See also

Intellectual developmental disorder Withdrawal symptoms, 259

Woodcock-Johnson Tests of Cognitive

Abilities, 91 Working memory, 157 Worries, developmental tasks and

challenges related to, 193–194

Yale-Brown Obsessive-Compulsive Scales

(Y-BOCS), 60, 209 Young adulthood

personality disorders, 268–270 psychotic disorders, 270–274

Zero to Three Association, classification

system, 53–54 Zigler, Edward, 93

DSM-5-TR Classifications

Neurodevelopmental Disorders

Intellectual Disabilities

Intellectual Disability (Intellectual

Developmental Disorder)/Global Developmental Delay/Unspecified Intellectual Disability (Intellectual Developmental Disorder)

Communication Disorders

Language Disorder/Speech Sound

Disorder/Childhood-Onset Fluency Disorder (Stuttering)/Social (Pragmatic) Communication Disorder/Unspecified Communication Disorder

Autism Spectrum Disorder

Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder/

Other Specified Attention-Deficit/ Hyperactivity Disorder/Unspecified Attention-Deficit/Hyperactivity Disorder

Specific Learning Disorder Motor Disorders

Developmental Coordination Disorder/

Stereotypic Movement Disorder

Tic Disorders

Tourette’s Disorder/Persistent (Chronic)

Motor or Vocal Tic Disorder/Provisional Tic Disorder/Other Specified Tic Disorder/Unspecific Tic Disorder

Other Neurodevelopmental Disorders

Other Specified Neurodevelopmental

Disorder/Unspecified Neurodevelopmental Disorder

Schizophrenia Spectrum and other Psychotic Disorders

Schizotypal (Personality) Disorder Delusional Disorder Brief Psychotic Disorder Schizophreniform Disorder Schizophrenia Schizoaffective Disorder Substance/Medication-Induced Psychotic

Disorder

Psychotic Disorder Due to Another

Medical Condition

Catatonia Associated with Another Mental

Disorder

Catatonic Disorder due to Another

Medical Condition

Unspecified Catatonia Other Specified Schizophrenia Spectrum

and Other Psychotic Disorder

Unspecified Schizophrenia Spectrum and

Other Psychotic Disorder

Bipolar and Related Disorders

Bipolar I Disorder/Bipolar II Disorder/

Cyclothymic Disorder/Substance/ Medication-Induced Bipolar and Related Disorder/Bipolar and Related Disorder Due to Another Medical Condition/ Other Specified Bipolar and Related Disorder/Unspecified Bipolar and Related Disorder

Depressive Disorders

Disruptive Mood Dysregulation Disorder/

Major Depressive Disorder/Persistent Depressive Disorder (Dysthymia)/ Premenstrual Dysphoric Disorder/ Substance/Medication-Induced Depressive Disorder/Depressive Disorder Due to Another Medical Condition/Other Specified Depressive Disorder/Unspecified Depressive Disorder

Anxiety Disorders

Separation Anxiety Disorder/Selective

Mutism/Specific Phobia/Social Anxiety Disorder (Social Phobia)/ Panic Disorder/Panic Attack Specifier/ Agoraphobia/Generalized Anxiety Disorder/Substance/Medication-Induced Anxiety Disorder/Anxiety Disorder Due to Another Medical Condition/Other Specified Anxiety Disorder/Unspecified Anxiety Disorder

Obsessive-Compulsive and Related Disorders

Obsessive-Compulsive Disorder/Body

Dysmorphic Disorder/Hoarding Disorder/Trichotillomania (Hair-Pulling Disorder)/Excoriation (Skin-Picking) Disorder/Substance/Medication-Induced Obsessive-Compulsive and Related Disorder/Obsessive-Compulsive and Related Disorder Due to Another Medical Condition/Other Specified Obsessive-Compulsive and Related Disorder/Unspecified ObsessiveCompulsive and Related Disorder

Trauma- and Stressor-Related Disorders

Reactive Attachment Disorder/

Disinhibited Social Engagement Disorder/Posttraumatic Stress Disorder (includes Posttraumatic Stress Disorder for Children 6 Years and Younger)/Acute Stress Disorder/Adjustment Disorders/ Other Specified Trauma- and StressorRelated Disorder/Unspecified Traumaand Stressor-Related Disorder

Dissociative Disorders

Dissociative Identity Disorder/Dissociative

Amnesia/Depersonalization/ Derealization Disorder/Other Specified Dissociative Disorder/Unspecified Dissociative Disorder

Somatic Symptom and Related Disorders

Somatic Symptom Disorder/Illness

Anxiety Disorder/Conversion Disorder (Functional Neurological Symptom Disorder)/Psychological Factors Affecting Other Medical Conditions/ Factitious Disorder (includes Factitious Disorder Imposed on Self, Factitious Disorder Imposed on Another)/ Other Specified Somatic Symptom and Related Disorder/Unspecified Somatic Symptoms and Related Disorder

Feeding and Eating Disorders

Pica/Rumination Disorder/Avoidant/

Restrictive Food Intake Disorder/ Anorexia Nervosa (Restricting type, Binge-eating/Purging type)/Bulimia Nervosa/Binge-Eating Disorder/Other Specified Feeding or Eating Disorder/ Unspecified Feeding or Eating Disorder

Elimination Disorders

Enuresis/Encopresis/Other Specified

Elimination Disorder/Unspecified Elimination Disorder

Sleep-Wake Disorders

Insomnia Disorder

Hypersomnolence Disorder/Narcolepsy

Breathing-Related Sleep Disorders

Obstructive Sleep Apnea Hypopnea/

Central Sleep Apnea/Sleep-Related

DSM-5-TR Classifications

Hypoventilation/Circadian Rhythm Sleep–Wake Disorders

Parasomnias

Nonrapid Eye Movement Sleep Arousal

Disorders/Nightmare Disorder/Rapid Eye Movement Sleep Behavior Disorder/ Restless Legs Syndrome/Substance/ Medication-Induced Sleep Disorder/ Other Specified Insomnia Disorder/ Unspecified Insomnia Disorder/Other Specified Hypersomnolence Disorder/ Unspecified Hypersomnolence Disorder/ Other Specified Sleep–Wake Disorder/ Unspecified Sleep–Wake Disorder

Sexual Dysfunctions

Delayed Ejaculation/Erectile Disorder/

Female Orgasmic Disorder/Female Sexual Interest/Arousal Disorder/ Genito-Pelvic Pain/Penetration Disorder/Male Hypoactive Sexual Desire Disorder/Premature (Early) Ejaculation/ Substance/Medication-Induced Sexual Dysfunction/Other Specified Sexual Dysfunction/Unspecified Sexual Dysfunction

Gender Dysphoria

Gender Dysphoria/Other Specified

Gender Dysphoria/Unspecified Gender Dysphoria

Disruptive, Impulse-Control, and Conduct Disorders

Oppositional Defiant Disorder/

Intermittent Explosive Disorder/ Conduct Disorder/Antisocial Personality Disorder/Pyromania/Kleptomania/ Other Specified Disruptive, ImpulseControl, and Conduct Disorder/ Unspecified Disruptive, ImpulseControl, and Conduct Disorder

Substance-Related and Addictive Disorders

Substance-Related Disorders

Alcohol-Related Disorders: Alcohol Use

Disorder/Alcohol Intoxication/Alcohol Withdrawal/Other Alcohol-Induced Disorders/Unspecified Alcohol-Related Disorder

Caffeine-Related Disorders: Caffeine

Intoxication/Caffeine Withdrawal/Other

Caffeine-Induced Disorders/Unspecified Caffeine-Related Disorder

Cannabis-Related Disorders: Cannabis

Use Disorder/Cannabis Intoxication/ Cannabis Withdrawal/Other CannabisInduced Disorders/Unspecified Cannabis-Related Disorder

Hallucinogen-Related Disorders:

Phencyclidine Use Disorders/ Other Hallucinogen Use Disorder/ Phencyclidine Intoxication/Other Hallucinogen Intoxication/Hallucinogen Persisting Perception Disorder/Other Phencyclidine-Induced Disorders/ Other Hallucinogen-Induced Disorders/ Unspecified Phencyclidine-Related Disorders/Unspecified HallucinogenRelated Disorders

Inhalant-Related Disorders: Inhalant Use

Disorder/Inhalant Intoxication/Other Inhalant-Induced Disorders/Unspecified Inhalant-Related Disorders

Opioid-Related Disorders: Opioid Use

Disorder/Opioid Intoxication/Opioid Withdrawal/Other Opioid-Induced Disorders/Unspecified Opioid-Related Disorder

Sedative-, Hypnotic-, or Anxiolytic-

Related Disorders: Sedative, Hypnotic, or Anxiolytic Use Disorder/Sedative, Hypnotic, or Anxiolytic Intoxication/ Sedative, Hypnotic, or Anxiolytic Withdrawal/Other Sedative-, Hypnotic-, or Anxiolytic-Induced Disorders/ Unspecified Sedative-, Hypnotic-, or Anxiolytic-Related Disorder

Stimulant-Related Disorders: Stimulant

Use Disorder/Stimulant Intoxication/ Stimulant Withdrawal/Other StimulantInduced Disorders/Unspecified Stimulant-Related Disorder

Tobacco-Related Disorders: Tobacco Use

Disorder/Tobacco Withdrawal/Other Tobacco-Induced Disorders/Unspecified Tobacco-Related Disorder

Other (or Unknown) Substance-Related

Disorders: Other (or Unknown) Substance Use Disorder/Other (or Unknown) Substance Intoxication/Other (or Unknown) Substance Withdrawal/ Other (or Unknown) Substance-Induced Disorders/Unspecified Other (or Unknown) Substance-Related Disorder

Non-Substance-Related Disorders

Gambling Disorder

Neurocognitive Disorders

Delirium

Major and Mild Neurocognitive Disorders